4/A
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0001209191-22-040294
Options or other derivatives
- Director acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Colangelo Dominick Director | 2022-06-23 | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | D: show line 1 in the form |
Loading xslF345X03/doc4a.xml…